Search

everythinglearnresearchcommunity

for

Search:↓

Early detection and histopathology are crucial to prevent permanent hair loss in cicatricial alopecia.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Current treatments for cicatricial alopecia can manage symptoms but don't stop hair loss or the disease.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Accurate diagnosis and tailored treatment are crucial for managing complex hair loss conditions.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.

Erlotinib can cause hair loss as a side effect.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Some cases of tinea capitis, a fungal scalp infection, can look like scarring hair loss due to the body's immune response and the fungus itself.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

CCCA is a common scarring hair loss in African descent women, possibly linked to genetics, hair care practices, and health issues like diabetes.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Most patients with cicatricial alopecias face significant psychological and social challenges due to their hair loss.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

The study suggests computer-assisted analysis of scalp biopsies could improve hair loss diagnosis but needs more validation.

Deleting the Far2 gene in mice causes sebaceous gland issues and patchy hair loss.

Tissue expansion is an effective treatment for certain types of hair loss, providing immediate coverage with hair-bearing skin.

Cicatricial alopecia is caused by skin conditions like lupus and lichen planus, leading to scarring and hair loss.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

Middle-aged women in Iran are most affected by primary cicatricial alopecia, especially discoid lupus erythematous.

Severe CCCA may be biologically and clinically different from milder forms.

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

Dermatoscopy can help diagnose CCCA without visible hair loss, offering a less invasive option than biopsy.